PPAR gamma agonists for treatment of multiple sclerosis

1. A method of treating relapsing and remitting multiple sclerosis (RRMS) in a patient in need thereof comprising administering to said patient at regular dosing intervals of a pharmaceutical composition comprising a therapeutically effective amount of a compound of formula (I),

or a pharmaceutically acceptable salt, prodrug, or isomer thereof.

2. A method of treating the symptoms of RRMS comprising administering to a patient in need thereof a compound of formula (I),

or a pharmaceutically acceptable salt, prodrug or isomer thereof

3. A method of providing neuroprotection to a patient with gray matter atrophy comprising administering a compound of the formula (I),

or a pharmaceutically acceptable salt, prodrug or isomer thereof.

4. A method of treating the symptoms of neuroinflammation comprising administering to a patient in need thereof a compound of formula (I),

or a pharmaceutically acceptable salt, prodrug or isomer thereof.